Matches in Nanopublications for { ?s ?p "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP154699.RA3mkKmSUlNXCMQ357wGFygkI5T22RON-uxAkoJWhjCkw130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154699.RA3mkKmSUlNXCMQ357wGFygkI5T22RON-uxAkoJWhjCkw130_provenance.
- NP554446.RAWLK3ZKFTralMAKBPMLkp1b8WQu9yGZY348o4trDFs5M130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554446.RAWLK3ZKFTralMAKBPMLkp1b8WQu9yGZY348o4trDFs5M130_provenance.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_provenance.
- assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP754136.RATGicBptxdEiRF_Xxu9ytZGg_f29xOTmCTvwNDq2CG2o130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754136.RATGicBptxdEiRF_Xxu9ytZGg_f29xOTmCTvwNDq2CG2o130_provenance.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_provenance.
- NP754134.RA8GOAH7LXXA-M-fH3nkgi1sx4NHFqwi63nOkOwYKtKp4130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754134.RA8GOAH7LXXA-M-fH3nkgi1sx4NHFqwi63nOkOwYKtKp4130_provenance.
- NP754135.RA1nOC6yMfnO_zF_TNliSsWMQy5N0KqL2vo44FFu7fB7E130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754135.RA1nOC6yMfnO_zF_TNliSsWMQy5N0KqL2vo44FFu7fB7E130_provenance.